Antigen News and Research

RSS
Differences in symptoms and risk of hospitalization following infection with Omicron or Delta SARS-CoV-2 variants among vaccinated people

Differences in symptoms and risk of hospitalization following infection with Omicron or Delta SARS-CoV-2 variants among vaccinated people

12 Apr 2022
SARS-CoV-2 mutations change proteasome processing to alter CD8+ T cell responses

SARS-CoV-2 mutations change proteasome processing to alter CD8+ T cell responses

12 Apr 2022
Unique heightened aggregation of SARS-CoV-2 Delta variant spike pseudotyped particles

Unique heightened aggregation of SARS-CoV-2 Delta variant spike pseudotyped particles

12 Apr 2022
Nanocell COVID-19 vaccine elicits potent neutralizing response

Nanocell COVID-19 vaccine elicits potent neutralizing response

11 Apr 2022
NK cells combined with bispecific antibody achieve effective responses in patients with lymphoma

NK cells combined with bispecific antibody achieve effective responses in patients with lymphoma

11 Apr 2022
Prime-pull immunization of mice with novel subunit vaccine elicits mucosal immunity to prevent severe SARS CoV-2 infection

Prime-pull immunization of mice with novel subunit vaccine elicits mucosal immunity to prevent severe SARS CoV-2 infection

11 Apr 2022
The effect of unsuppressed HIV on T-cell response to COVID-19

The effect of unsuppressed HIV on T-cell response to COVID-19

10 Apr 2022
Shared gene expression signatures in type 1 diabetics treated with IL-2 and COVID-19 patients

Shared gene expression signatures in type 1 diabetics treated with IL-2 and COVID-19 patients

10 Apr 2022
Preliminary data from clinical trial reveals safety, efficacy of new CAR T-cell therapy for solid tumors

Preliminary data from clinical trial reveals safety, efficacy of new CAR T-cell therapy for solid tumors

10 Apr 2022
B-cells have significant differences in women with postpartum depression, finds study

B-cells have significant differences in women with postpartum depression, finds study

10 Apr 2022
New delivery method enhances the "attack power" of CAR T cells against tumors

New delivery method enhances the "attack power" of CAR T cells against tumors

8 Apr 2022
City of Hope's late-breaking clinical trial data to be presented at AACR

City of Hope's late-breaking clinical trial data to be presented at AACR

8 Apr 2022
SARS-CoV-2 Omicron variant spike-specific unique cluster of differentiation cells

SARS-CoV-2 Omicron variant spike-specific unique cluster of differentiation cells

8 Apr 2022
SARS-CoV-2 Delta-Omicron recombinant identified in a transplant patient treated with Sotrovimab

SARS-CoV-2 Delta-Omicron recombinant identified in a transplant patient treated with Sotrovimab

8 Apr 2022
Study characterizes SARS-CoV-2 spike-specific cluster of differentiation 4+ T-cell response

Study characterizes SARS-CoV-2 spike-specific cluster of differentiation 4+ T-cell response

8 Apr 2022
Scientists are searching for the ‘perfect protein’ to develop mRNA-based malaria vaccine

Scientists are searching for the ‘perfect protein’ to develop mRNA-based malaria vaccine

7 Apr 2022
Study on the viral dynamics of Omicron and Delta infected individuals

Study on the viral dynamics of Omicron and Delta infected individuals

7 Apr 2022
SARS-CoV-2 mutations capable of widespread T-cell escape

SARS-CoV-2 mutations capable of widespread T-cell escape

7 Apr 2022
UGA researchers develop nanotechnology-based optical sensors for rapid coronavirus detection

UGA researchers develop nanotechnology-based optical sensors for rapid coronavirus detection

7 Apr 2022
Study suggests blunted serological responses not responsible for COVID-19 mortality

Study suggests blunted serological responses not responsible for COVID-19 mortality

7 Apr 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback